This paper is in the following e-collection/theme issue:

Opinion: Viewpoints, Columns, and Perspectives (9) Digital Science, Open Science (70) Data Science (232) Knowledge Translation and Implementation Science (375) Viewpoints and Perspectives (485) Policy and Policy Proposals (115) Innovations in Clinical Trials and Research Data Management (73)

Published on in Vol 13, No 1 (2021): Jan-Mar

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23011, first published .
Data Sharing Goals for Nonprofit Funders of Clinical Trials

Data Sharing Goals for Nonprofit Funders of Clinical Trials

Data Sharing Goals for Nonprofit Funders of Clinical Trials

Authors of this article:

Timothy Coetzee1 Author Orcid Image ;   Mad Price Ball2 Author Orcid Image ;   Marc Boutin3 Author Orcid Image ;   Abby Bronson4 Author Orcid Image ;   David T Dexter5 Author Orcid Image ;   Rebecca A English6 Author Orcid Image ;   Patricia Furlong7 Author Orcid Image ;   Andrew D Goodman8 Author Orcid Image ;   Cynthia Grossman9 Author Orcid Image ;   Adrian F Hernandez10 Author Orcid Image ;   Jennifer E Hinners11 Author Orcid Image ;   Lynn Hudson12 Author Orcid Image ;   Annie Kennedy7 Author Orcid Image ;   Mary Jane Marchisotto13 Author Orcid Image ;   Lynn Matrisian14 Author Orcid Image ;   Elizabeth Myers15 Author Orcid Image ;   W Benjamin Nowell16 Author Orcid Image ;   Brian A Nosek17 Author Orcid Image ;   Todd Sherer18 Author Orcid Image ;   Carolyn Shore6 Author Orcid Image ;   Ida Sim19 Author Orcid Image ;   Luba Smolensky18 Author Orcid Image ;   Christopher Williams20 Author Orcid Image ;   Julie Wood21 Author Orcid Image ;   Sharon F Terry22 Author Orcid Image
Article Authors Cited by (1) Tweetations (22) Metrics

Timothy Coetzee   1 , MSc, PhD ;   Mad Price Ball   2 , PhD ;   Marc Boutin   3 , JD ;   Abby Bronson   4 , MBA ;   David T Dexter   5 , PhD ;   Rebecca A English   6 , MPH ;   Patricia Furlong   7 , BSN ;   Andrew D Goodman   8 , MD ;   Cynthia Grossman   9 , PhD ;   Adrian F Hernandez   10 , MD, MHS ;   Jennifer E Hinners   11 , MPH, MD ;   Lynn Hudson   12 , PhD ;   Annie Kennedy   7 , BSc ;   Mary Jane Marchisotto   13 , MBA ;   Lynn Matrisian   14 , PhD, MBA ;   Elizabeth Myers   15 , PhD ;   W Benjamin Nowell   16 , PhD ;   Brian A Nosek   17 , PhD ;   Todd Sherer   18 , PhD ;   Carolyn Shore   6 , PhD ;   Ida Sim   19 , PhD, MD ;   Luba Smolensky   18 , BA ;   Christopher Williams   20 , MSc ;   Julie Wood   21 , BA ;   Sharon F Terry   22 , MA, LhD

1 National Multiple Sclerosis Society, Cherry Hill, NJ, United States

2 Open Humans Foundation, San Diego, CA, United States

3 Novartis, Basel, Switzerland

4 Edgewise Therapeutics, Boulder, CO, United States

5 Parkinson’s UK, London, United Kingdom

6 National Academies of Sciences, Engineering, and Medicine, Washington, DC, United States

7 Parent Project Muscular Dystrophy, Bethesda, MD, United States

8 Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States

9 Biogen, Cambridge, MA, United States

10 Duke University School of Medicine, Durham, NC, United States

11 Bison Ink, Washington, DC, United States

12 Critical Path Institute, Tucson, AZ, United States

13 MJM Advisory, LLC, New York, NY, United States

14 Pancreatic Cancer Action Network, Washington, DC, United States

15 Doris Duke Charitable Foundation, New York, NY, United States

16 Global Healthy Living Foundation, Upper Nyack, NY, United States

17 Center for Open Science, Charlottesville, VA, United States

18 The Michael J Fox Foundation for Parkinson’s Research, New York, NY, United States

19 Department of Medicine, University of California San Francisco, San Francisco, CA, United States

20 Multiple Myeloma Research Foundation, Norwalk, CT, United States

21 Vivli, Columbia, MO, United States

22 Genetic Alliance, Washington, DC, United States

Corresponding Author: